Fact CheckerSign in

NCT06354491Active, not recruiting

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

An Imaging-based Quantitative Biomarker Assay for Non-alcoholic Fatty Liver Disease (NAFLD) in Children: a Feasibility Study

Source: ClinicalTrials.gov · Last updated 17 Dec 2025

Brief summary (registry, in English)

This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
24 (actual)
First submitted
3 Apr 2024
Start date
1 Apr 2024
Primary completion date
20 Jun 2025
Lead sponsor
University of Wisconsin, Madison
NCT number
NCT06354491

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 1 Apr 2024 to the primary completion date, 20 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Children with contraindications to MRI.
  • Children who did not fast (verbally confirmed by children or guardian)
  • Pregnant

Who the study is looking for

  • Age: 10 - 14years old
  • BMI: Case subjects: BMI\>95th percentile for age and sex Healthy BMI volunteers: 5th ≤ BMI \< 85th percentile for age and sex

Age in the registry: 10 years to 14 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Wisconsin - Madison
Coordinator of this site? Confirm its status		MadisonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.